30
Jan 2026
A team of researchers from the Andalusian Centre for Molecular Biology and Regenerative Medicine (CABIMER) and the University of Seville, in collaboration with the Virgen Macarena University Hospital, have identified a fundamental mechanism that links the 24-hour circadian cycle to the precise repair of DNA breaks.
30
Jan 2026
If severe DNA damage is not repaired, the consequences for the health of cells and tissues are dramatic.
30
Jan 2026
New research by UCLA Health and UC San Francisco has uncovered why certain brain cells are more resilient than others to the buildup of a toxic protein that is a hallmark of Alzheimer's disease and related dementias, potentially leading to new targets for therapies or treatments.
30
Jan 2026
With cardiovascular disease remaining the leading cause of death in the United States, this Heart Month (February), FIU is establishing an interdisciplinary center designed to accelerate breakthroughs in heart disease research, education, and innovation.
30
Jan 2026
Continuous monitoring of biomarkers is essential for early disease detection, treatment evaluation, and personalized health management, yet most clinical tests rely on invasive, single-point blood sampling. Recent advances in aptamer-based wearable electrochemical sensors offer a promising alternative by enabling real-time, continuous tracking of physiological signals directly in or on the body.
30
Jan 2026
She has written a doctoral thesis on health-related quality of life among children and young people in Agder.
30
Jan 2026
Barbara Tuszynski was concerned about her vision but confident in her insurance coverage when she went to an eye clinic last May.
30
Jan 2026
An enduring challenge for the study of human cancer is just how complex it is: how many different ways there are for cancers to originate, progress, and spread in the people who are diagnosed with them.
30
Jan 2026
Lydia Romero strained to hear her husband's feeble voice through the phone.
30
Jan 2026
Researchers at NYU Abu Dhabi have developed a new light-based nanotechnology that could improve how certain cancers are detected and treated, offering a more precise and potentially less harmful alternative to chemotherapy, radiation, and surgery.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
